• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTACT VASCULAR TACK ENDOVASCULAR SYSTEM (6F, 3.5-6.0MM); SCAFFOLD, DISSECTION REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTACT VASCULAR TACK ENDOVASCULAR SYSTEM (6F, 3.5-6.0MM); SCAFFOLD, DISSECTION REPAIR Back to Search Results
Catalog Number 156135061
Device Problem Off-Label Use (1494)
Patient Problem Thrombus (2101)
Event Date 03/02/2020
Event Type  Injury  
Manufacturer Narrative
The device has not been returned to intact vascular at the time of this report and is not expected to be returned.If additional information is received after this report, a supplemental report will be submitted.There is no conclusive evidence at this time that the tack implant contributed to the occlusion.
 
Event Description
Right limb p2/p3 observed to be occluded 1-week post dissection repair using tack endovascular system (6f, 3.5-6.0mm).On (b)(6) 2020, physician implanted 6 tacks (6f tack endovascular system (6f, 3.5-6.0mm)lot# 206193)in patient's right limb (p2/p3) to repair post pta observed dissection.Note: 6f tack endovascular system (6f, 3.5-6.0mm) is indicated for use in superficial femoral artery (sfa) and proximal popliteal (p1) region.Use of the device within p2/p3 was used off-label by physician at their discretion and without any on-site intact vascular sales team support.On (b)(6) 2020 (one week post initial intervention), the physician was performing a previously scheduled intervention on the patient's left limb, a right limb runoff was also performed and occlusion observed within the tack implanted p2/p3 region (the tack implants were deployed one week prior during the procedure that occurred on (b)(6) 2020).Intact vascular was notified about the adverse event "occlusion within implanted tacks region" on (b)(6) 2020.Patient was scheduled to return to treat occlusion on (b)(6) 2020.During the re-intervention to resolve the observed occlusion, laser artherectomy was performed by the physician and the occlusion was resolved and blood flow restored.This event is being reported as additional intervention was performed to treat the observed obstruction of the vessel in the tack implant section of p2/p3 to restore flow.There is no conclusive evidence at this time that the tack implant contributed to the occlusion.No further adverse events have been reported to intact vascular since the re-intervention performed on (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACK ENDOVASCULAR SYSTEM (6F, 3.5-6.0MM)
Type of Device
SCAFFOLD, DISSECTION REPAIR
Manufacturer (Section D)
INTACT VASCULAR
1285 drummers lane
suite 200
wayne, pa
Manufacturer Contact
joseph griffin iii
1285 drummers lane
suite 200
wayne, pa 
2531048
MDR Report Key9898387
MDR Text Key196628886
Report Number3012608866-2020-00001
Device Sequence Number1
Product Code QCT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number156135061
Device Lot Number206193
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/02/2020
Initial Date FDA Received03/30/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/22/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-